dc.creatorUniversidad San Sebastián
dc.creatorUniversidad San Sebastián
dc.creatorUniversidad San Sebastián
dc.creatorUniversidad San Sebastián
dc.creatorUniversidad San Sebastián
dc.creatorUniversidad San Sebastián
dc.creatorEspinoza-Derout, Jorge
dc.creatorShao, Xuesi M.
dc.creatorLao, Candice J.
dc.creatorHasan, Kamrul M.
dc.creatorRivera, Juan Carlos
dc.creatorJordan, Maria C.
dc.creatorEcheverria, Valentina
dc.creatorRoos, Kenneth P.
dc.creatorSinha-Hikim, Amiya P.
dc.creatorFriedman, Theodore C.
dc.date.accessioned2023-05-24T04:46:27Z
dc.date.available2023-05-24T04:46:27Z
dc.date.created2023-05-24T04:46:27Z
dc.date.issued2022-04-07
dc.identifier2297-055X
dc.identifierhttps://repositorio.uss.cl/handle/uss/5956
dc.identifier10.3389/fcvm.2022.879726
dc.description.abstractElectronic cigarettes or e-cigarettes are the most frequently used tobacco product among adolescents. Despite the widespread use of e-cigarettes and the known detrimental cardiac consequences of nicotine, the effects of e-cigarettes on the cardiovascular system are not well-known. Several in vitro and in vivo studies delineating the mechanisms of the impact of e-cigarettes on the cardiovascular system have been published. These include mechanisms associated with nicotine or other components of the aerosol or thermal degradation products of e-cigarettes. The increased hyperlipidemia, sympathetic dominance, endothelial dysfunction, DNA damage, and macrophage activation are prominent effects of e-cigarettes. Additionally, oxidative stress and inflammation are unifying mechanisms at many levels of the cardiovascular impairment induced by e-cigarette exposure. This review outlines the contribution of e-cigarettes in the development of cardiovascular diseases and their molecular underpinnings.
dc.languageeng
dc.relationFrontiers in Cardiovascular Medicine
dc.titleElectronic Cigarette Use and the Risk of Cardiovascular Diseases
dc.typeArtículo


Este ítem pertenece a la siguiente institución